ÖZET
Çin’in Wuhan şehrinde Aralık 2019’da nedeni belirlenemeyen pnömoni ile karakterize, ciddi akut solunum sıkıntıcı sendromuna yol açan bir salgın başlamıştır. Salgının etkeninin yeni bir koronavirüs olan şiddetli akut solunum yetersizliği sendromu-2 (SARS-CoV-2) olduğu saptanıp kısa bir süre içinde hızla yayılım göstermesiyle Dünya Sağlık Örgütü tarafından halk sağlığı açısından acil durum olan pandemi olarak ilan edilmiştir. Virüs başlıca hastaların sekresyonları ile doğrudan temas ile virüs içeren mikrodamlacıkların inhalasyonu ile bulaşmaktadır. Virüsün oküler yol ile bulaşması ise tartışmalı bir konu olup literatürde sınırlı sayıda çalışma mevcuttur. Foliküler konjonktivitin hastalığın oküler bulgularından biri olabileceği ve eşlik eden konjonktivit olmasa dahi özellikle oftalmologların ve sağlık çalışanlarının koruyucu önlemler almaları oldukça önem taşımaktadır. Bu derlemede SARSCoV-2’nin oküler yüzey bulguları ile ilişkisi literatür eşliğinde değerlendirilmiştir.
References
1
Madhugiri R, Fricke M, Marz M, Ziebuhr J. Coronavirus cis-acting RNA elements. Adv Virus Res 2016;96:127-63.
2
Salata C, Calistri A, Parolin C, Palù G. Coronaviruses: A paradigm of new emerging zoonotic diseases. Pathog Dis 2019;77:1-5.
3
Woo PC, Lau SK, Huang Y, Yuen KY. Coronavirus diversity, phylogeny and interspecies jumping. Exp Biol Med (Maywood) 2009;234:1117-27.
4
Habibzadeh P, Stoneman EK. The Novel Coronavirus: A Bird’s Eye View. Int J Occup Environ Med 2020;11:65-71.
5
Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 2016;24:490-502.
6
Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm 2020;28:391-5.
7
Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and sources of endemic human coronaviruses. Adv Virus Res 2018;100:163-88.
8
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33.
9
World Health Organization. Novel coronavirus (2019-nCoV) situation report-1. 21 January 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf?sfvrsn=20a99c10_4%203.
10
World Health Organization. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.
11
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506.
12
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13.
13
Napoli PE, Nioi M, d’Aloja E, Fossarello M. The ocular surface and the coronavirus disease 2019: Does a dual ‘ocular route’ exist? J Clin Med 2020;9:1269.
14
van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJ, Wolthers KC, et al. Identification of a new human coronavirus. Nat Med 2004;10:368-73.
15
Vabret A, Mourez T, Dina J, van der Hoek L, Gouarin S, Petitjean J, et al. Human coronavirus NL63, France. Emerg Infect Dis 2005;11:1225-9.
16
Loon SC, Teoh SC, Oon LL, Se-Thoe SY, Ling AE, Leo YS, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 2004;88:861-3.
17
Chan WM, Yuen KS, Fan DS, Lam DS, Chan PK, Sung JJ. Tears and conjunctival scrapings for coronavirus in patients with SARS. Br J Ophthalmol 2004;88:968-9.
18
Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol 2020;104:748-51.
19
Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020;395:39.
20
Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 2020;92:589-94.
21
Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE, et al. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology 2020;127:977-9.
22
Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, et al. SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med 2020;173:242-3.
23
Fodoulian L, Tuberosa J, Rossier D, Boillat M, Kan C, Pauli V, et al. SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain. iScience 2020;23:101839.
24
Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus Interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020;11:995-8.
25
Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 2020;26:681-7.
26
Ma D, Chen CB, Jhanji V, Xu C, Yuan XL, Liang JJ, et al. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye (Lond) 2020;34:1212-9.
27
Napoli PE, Nioi M, Mangoni L, Gentile P, Braghiroli M, d’Aloja E, et al. Fourier-domain OCT imaging of the ocular surface and tear film dynamics: A review of the state of the art and an integrative model of the tear behavior during the inter-blink period and visual fixation. J Clin Med 2020;9:668.
28
Sun Y, Liu L, Pan X, Jing M. Mechanism of the action between the SARS-CoV S240 protein and the ACE2 receptor in eyes. Int. J Ophthalmol 2006;6:783-6.
29
Sun K, Gu L, Ma L, Duan Y. Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2. Heliyon 2021;7:05850.
